Amyloid-β peptides stimulate the expression of the p75NTR neurotrophin receptor in SHSY5Y human neuroblastoma cells and AD transgenic mice

Journal of Alzheimer's Disease

Volumn 19, Issue 3, 2010, Pages 915-925

  Chakravarthy, Balu ^a   Gaudet, Chantal ^a   Ménard, Michel ^a   Atkinson, Trevor ^a   Brown, Leslie ^a   Laferla, Frank M ^b   Armato, Ubaldo ^c   Whitfield, James ^a  

^a NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF VERONA   (Italy)

Author keywords

Alzheimer's disease; Amyloid peptides; Human neuroblastomas; SH SY5Y human neuroblastomas; Transgenic mice

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; AMYLOID BETA PROTEIN[25-35]; NEUROTROPHIN RECEPTOR P75;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN CELL; IMMUNOHISTOLOGY; MOUSE; MOUSE STRAIN; NERVE CELL MEMBRANE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WESTERN BLOTTING;

EID: 77149138009     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2010-1288     Document Type: Article

References (46)

1. Sisodia SS, Tanzi RE (2007) Alzheimer's Disease. Advances in Genetics and Cellular Biology. Springer Science+Business Media, LLC, New York.
2. Dean R, Zlokovic BV (2007) Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. Curr Alzheimer Res 4, 191-197.
3. Huong S-M, Mouri A, Kokubo H, Nakajima R, Suemoto T, Higuchi M, Staufenbiel M, Noda Y, Yamaguchi H, Nabeshima T, Saido T, Iwata N (2006) Neprilysin-sensitive synapseassociated amyloid peptide oligomers impair neuronal plasticity and cognitive function. J Biol Chem 281, 17941-17951.
4. Marques MA, Kulstad JJ, Savard CE, Green PS, Lee SP, Craft S, Watson GS, Cook DG (2009) Peripheral amyloid-β levels regulate amyloid-β clearance from the central nervous system. J Alzheimers Dis 16, 325-329.
5. Nicoll JA,Yamada M, Frankowiak J, Mazur-Kolecka B,Weller RO (2004) Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Pro-CAA position statement. Neurobiol Aging 25, 589-597.
6. Whitfield JF (2007) The road to LOADlate-onset Alzheimer's disease and a possible way to block it. Expert Opin Ther Targets 11, 1257-1260.
7. Bokde ALW, Ewers M, Hample H (2009) Assessing neuronal networks: understanding Alzheimer's disease. Prog Neurobiol 89, 125-133.
8. Huang J, Friedland RP, Auchus AP (2007) Diffusion tensor imaging of normal-appearing white matter in mild cognitive impairment and early Alzheimer disease: preliminary evidence of axonal degeneration in the temporal lobe. AJNR Am J Neuroradiol 28, 1943-1948.
9. Klein WL, Lacor PN, De Felice FG, Ferreira ST (2007) Molecules that disrupt memory circuits in Alzheimer's disease: the attack on synapses by A oligomers (ADDLS). In Memories: Molecules and Circuits, Bontempi B, Silva AJ, Christen Y, eds. Springer Verlag, Berlin, pp. 155-179.
10. Selkoe DJ (2008) Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior. Behav Brain Res 192, 106-113.
11. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM, Walsh DM, Sabatini BL, Selkoe DJ (2008) amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14, 837-842.
12. Ashe KH (2007) Cognitive impairment in transgenic Aβ and tau models of Alzheimer's disease. In Alzheimer's Disease, Sisodia SS, Tanzi RE, eds. Springer Science Business Media, LLC, New York, pp. 78-91.
13. Chiarini A, Dal Pra L Whitfield JF, Armato U (2006) The killing of neurons by β-amyloid peptides prions, and proinflammatory cytokines. Ital J Anat Embryol 111, 221-246.
14. Constantini C,Weindruch R, Della Valle, G, Puglielli L (2005) A Trk A-to-p75NTR molecular switch activates β-peptide generation during aging. Biochem J 391, 59-67.
15. Constantini C, Scrable H, Puglielli L (2006) An aging pathway controls the TrkA top75NTR rcceptor switch and amyloid β-peptide generation. EMBO J 25, 1997-2006.
16. Kuner P, Schubenel R, Hertel C (1998) Beta-amyloid binds to p75NTR and activates NF-.βB in human neuroblastoma cells. J Neurosci Res 54, 798-804.
17. Perini G, Della-Bianca V, Politi V, Della Valle G, Dal Pra I, Rossi F, Armato U (2002) Role of p75 neurotrophin receptor in the neurotoxicity by beta-amyloid peptides and the synergistic effect of inflammatory cytokines. J Exp Med 195, 907-918.
18. Yaar M, Zhai S, Pilch PF, Doyle SM, Eisenhauer PB, Fine RE, Gilchrest BA (1997) Binding of beta-amyloid to the p75NTR neurotrophin receptor induces apopotosis. A possible mechanism for Alzheimer's disease. J Clin Invest 100, 2333-2340.
19. Yaar M, Zhai S, Fine RE, Eisenhauer PB, Arbie BL, Stewart KB, Gilchrest BA (2001) amyloid-β binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling. J Biol Chem 277, 7720-7725.
20. Chakravarthy B,Walker T, Rasquinha I, Hill IE, MacManus JP (1999) Activation of DNA-dependent protein kinase may play a role in apoptosis of human neuroblastoma cells. J Neurochem 72, 933-942
21. Bradford MM (1976) A rapid and sensitive method for the quantitation of micro gram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254.
22. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
23. Chakravarthy B, Rashid A, Brown, L, Tessier L, Kelly J and Ḿenard M (2008) Association of Gap-43 (neuromodulin) with microtubule-associated protein MAP-2 in neuronal cells. Biochem Biophys Res Comm 371, 679-683
24. Atkinson TG, Whitfield J, and Chakravarthy B (2009) The phosphatase inhibitor, okadaic acid, strongly protects primary rat cortical neurons from lethal oxygen-glucose deprivation. Biochem Biophys Res Commun 378, 394-398
25. Oddo S, Caccamo A, Shepherd JD, Murphy MP, Golde TE, Kayed R, Metherate R, Mattson MP, Akbari Y, LaFerla FM (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39, 409-421.
26. Oddo S, Caccamo A, Kitazawa M, Tseng BP, LaFerla FM (2003) Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease. Neurobiol Aging 24, 1063-1070.
27. Billings LM, Oddo S, Green KN, McGaugh JL, LaFerla FM (2005) Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice. Neuron 45, 675-688.
28. Oddo S, Caccamo A, Smith IF, Green KN, LaFerla FM (2006) Adynamic relationship between intracellular and extracellular pools of Aβ. Am J Pathol 168, 184-194.
29. Gimenez-Llort L, Blazquez G, Canete T, Johansson B, Oddo S, Tobena A, Laferla FM, Fernandez-Teruel A (2007) Modeling behavioral and neuronal symptoms of Alzheimer's disease in mice: A role for intraneuronal amyloid. Neurosci Biobehav Rev 31, 125-147
30. Counts SE, Mufson EJ (2005) The role of nerve growth factor receptors in cholinergic basal forebrain degeneration in prodromal Alzheimer disease. J Neuropathol Exp Neurol 64, 263-272.
31. Ernfors P, Lindefors N, Chan-Palay V, Persson H (1990) Cholinergic neurons of the nucleus basalis express elevated levels of nerve growth factor receptor mRNA in senile dementia of the Alzheimer type. Dementia 1, 138-145.
32. Ginsberg SD, Che S, Wuu J, Counts SE, Mufson EJ (2006) Downregulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease. J Neurochem 97, 475-487.
33. Hock C, Hesse K, Muller-Spahn F, Hulette C, Rosenberg C, Otten U (1998) Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease. Neurosci Lett 241, 151-154.
34. Hu X-Y, Zhang H-Y, Qin S, Xu H, Swaab DF, Zhou J-N (2002) Increased p75NTR expression in hippocampal neurons containing hyperphosphorylated in Alzheimer patients. Exp Neurol 178, 104-111.
35. Mufson EJ, Kordorer JH (1992) Cortical neurons express nerve growth factor receptors in advanced age and Alzheimer disease. Proc Natl Acad Sci USA 89, 569-573.
36. Mufson EJ, Ma SY, Dills J, Cochran EJ, Leurgans S, Wuu J, J, Bennett DA, Jaffar S, Gilmor ML, Levey AI, Kordower JH (2002) Loss of basal forebrain P75 (NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J Comp Neurol 443, 136-153.
37. Salehi A, Ocampo M, Verhaagen J, Swaab DF (2000) P75 neurotrophin receptor in the nucleus basalis of Meynert in relatiuon to age, sex, and Alzheimer's disease. Exp Neurol 161, 245-258.
38. Savaskan E, Muller-Spahn F,Olivieri G, Bruttel S, Otten U (2000) B and trk C receptor immunoreactivities in parietal cortex and cerebellum in Alzheimer's disease. Eur Neurol 44, 172-180.
39. Yang T, Knowles JK, Lu Q, Zhang H, Arancio O, Moore LA, Chang T, Wang Q, Andreasson K, Rajadas J, Fuller GG, Xie Y, Massa SM, Longo FM (2008) Small molecule, non-peptide p75NTR ligands inhibit Aβ-induced neurodegeneration and synaptic impairment. PLoS One 3, e3606.
40. Blöchl A, Blöchl R (2007) Acell-biological model of p75NTR signaling. J Neurochem 102, 289-305.
41. Coulson EJ, Reid K, Baca M, Shipham KA, Hulette SM, Kilpatrick TJ, Bartlett PF (2000) Chopper, a new death domain of the p75 neurotrophin receptor that mediates rapid neuronal cell death. J Biol Chem 275, 30537-30545.
42. Coulson EJ (2006) Does the p75 neurotrophin receptor mediate Aβ-induced toxicity in Alzheimer's disease? J Neurochem 98, 654-660.
43. Dobrowsky RT, Carter BD (1998) Coupling of the p75 neurotrophin receptor to sphingolipid signaling. Ann NY Acad Sci 845, 32-45.
44. Puglielli L, Ellis BC, Saunders AJ, Kovacs DM (2003) Ceramide stabilizes β-site amyloid precursor protein-cleaving enzyme 1 and promotes amyloid β-peptide biogenesis. J Biol Chem 278, 19777-19783.
45. Sotthibundhu A, Sykes AM, Fox B, Underwood CK, Thangnipon W, Coulson EJ (2008) β Amyloid1-42 induces neuronal death through the p75 neurotrophin receptor. J Neurosci 28, 3941-3946.
46. Coulson EJ, May LM, Sykes AM, Hamlin AS (2009) The role of the p75 neurotrophin receptor in cholinergic dysfunction in Alzheimer's disease. Neuroscientist 15, 317-323.